Overall, the researchers found that:
- 32.1% of the study drugs reached the lungs in the overall group of participants.
- 35.2% of the study drugs reached the lungs in the participants with moderate COPD.
- 28.7% of the study drugs reached the lungs in the participants with severe or very severe COPD.

What medical problems happened during the study? This section is a summary of the medical problems the participants had during the study that the study doctors thought might be related to the study treatment. These medical problems are called "adverse reactions". An adverse reaction is considered "serious" when it is life-threatening, causes lasting problems, or requires hospital care.

This summary provides the average percentage of study drugs that reached the lungs:
- Participants: 32.1%
- Participants with moderate COPD: 35.2%
- Participants with severe or very severe COPD: 28.7%